U.S. market Closed. Opens in 17 hours 14 minutes

CALT | Calliditas Therapeutics AB (publ) Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312023-06-302022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Revenue1.21BN/A802.88M229.35M874.00K184.83MN/AN/AN/AN/A
Cost of Revenue77.06MN/A15.20MN/AN/AN/AN/AN/AN/AN/A
Gross Profit1.13BN/A787.68M229.35M874.00K184.83MN/AN/AN/AN/A
Operating Expenses1.51BN/A1.21B753.80M383.10M212.71M133.20M84.65M56.52M51.39M
Selling, General & Admin1.01BN/A774.66M390.23M141.72M62.88M133.15M84.60M56.41M51.28M
Research & Development499.54MN/A414.75M357.49M241.37M149.83MN/AN/AN/AN/A
Other Operating ExpensesN/AN/A20.21M6.08MN/AN/A51.00K51.00K112.00K111.00K
Operating Income-384.40MN/A-421.94M-524.46M-379.72M-28.02M-132.48M-84.51M-56.52M-51.39M
Other Expenses / Income-72.62MN/A12.53M11.08M-56.43M-4.48M1.15M-2.29M-395.00K375.00K
Before Tax Income-457.02MN/A-409.42M-513.37M-436.15M-32.50M-132.05M-86.79M-56.91M-51.01M
Income Tax Expenses9.17MN/A2.85M-3.84M360.00K77.00K441.00KN/AN/AN/A
Net Income-466.19MN/A-412.27M-509.54M-436.51M-32.58M-132.05M-86.79M-56.91M-51.01M
Interest Expenses73.20MN/A12.53M7.11M393.00K325.00K8.00K2.24M1.01M9.00K
Basic Shares Outstanding53.67M26.73M53.02M50.83M44.87M36.94M25.95M33.23M33.23M33.23M
Diluted Shares Outstanding53.67M26.73M53.02M50.83M44.87M36.94M25.95M33.23M33.23M33.23M
EBITDA-367.80MN/A-421.94M-524.46M-378.85M-25.13M-133.14M-84.50M-56.40M-51.28M
EBITDA Margin-30.48%0.00%-52.55%-228.67%-43,346.80%-13.60%0.00%0.00%0.00%0.00%
EBIT-383.82MN/A-396.89M-506.26M-435.76M-32.18M-131.60M-84.55M-55.90M-51.01M
EBIT Margin-31.80%0.00%-49.43%-220.74%-49,857.89%-17.41%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312023-06-302022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙